Monoamine Oxidase Type-B (MAO-B) inhibitors are a pivotal class of drugs used predominantly in the treatment of neurodegenerative disorders, including Parkinson’s disease and, to a lesser degree, Alzheimer’s disease. These inhibitors target the MAO-B enzyme, which metabolizes dopamine and other monoamines in the brain. By preventing this breakdown, MAO-B inhibitors increase dopamine...